Marpai (NASDAQ:MRAI – Get Free Report) is set to issue its quarterly earnings data after the market closes on Thursday, May 9th. Parties that wish to register for the company’s conference call can do so using this link.
Marpai (NASDAQ:MRAI – Get Free Report) last issued its quarterly earnings data on Tuesday, March 26th. The company reported ($0.65) earnings per share (EPS) for the quarter. The firm had revenue of $8.71 million for the quarter.
Marpai Stock Down 1.4 %
Shares of MRAI stock opened at $2.48 on Wednesday. The firm has a fifty day moving average of $2.18 and a 200-day moving average of $1.65. Marpai has a 12-month low of $0.33 and a 12-month high of $3.46. The company has a market capitalization of $25.54 million, a price-to-earnings ratio of -0.56 and a beta of 5.39.
Analyst Upgrades and Downgrades
Get Our Latest Stock Analysis on Marpai
Insider Activity at Marpai
In other Marpai news, CEO Damien Lamendola bought 910,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 7th. The stock was acquired at an average price of $1.65 per share, with a total value of $1,501,500.00. Following the completion of the transaction, the chief executive officer now owns 2,861,306 shares in the company, valued at $4,721,154.90. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 61.30% of the stock is owned by insiders.
About Marpai
Marpai, Inc, a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, bill review and cost containment services.
Recommended Stories
- Five stocks we like better than Marpai
- Insider Trades May Not Tell You What You Think
- Garmin Navigates to New Highs Driven By Wearables Trend
- What to Know About Investing in Penny Stocks
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- How to Invest in the Best Canadian Stocks
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Marpai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marpai and related companies with MarketBeat.com's FREE daily email newsletter.